{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:10:35Z","timestamp":1753891835157,"version":"3.41.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Proximal bronchial injury is a frequently observed complication in patients with central lung cancer following high-dose stereotactic body radiotherapy, whereas it is rarely reported after moderately hypofractionated radiotherapy. In this article, we present a case of proximal bronchial injury in a patient with small-cell lung cancer after moderately hypofractionated radiotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 45-year-old male patient with no history of smoking was diagnosed with limited stage small-cell lung cancer. According to guidelines of the National Comprehensive Cancer Network, the patient was treated with chemoradiotherapy, which included etoposide and cisplatin as well as radiotherapy at a dose of 65 Gy\/26 fractions. Three months after radiotherapy, the tumor disappeared; however, stenosis of the right main bronchus, right upper lobe bronchus, and intermediate bronchus, as well as atelectasis of the right upper and middle lobes, occurred and gradually worsened. Anti-infection and hormonal therapy were ineffective. One year after radiotherapy, grade 3 damage was formed in the proximal bronchus according to the Common Terminology Criteria for Adverse Events (version 5.0). Following endoscopic balloon dilatation of the right main bronchus, asthma symptoms of the patient were reduced.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This case reminds us that it is necessary to implement a proximal bronchial dose constraint and prevent the occurrence of dose hot spot in the proximal bronchus when administering moderately hypofractionated radiotherapy with a physical dose exceeding 65 Gy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1566693","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T05:15:56Z","timestamp":1747631756000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Proximal bronchial injury in small-cell lung cancer patient after moderately hypofractionated radiotherapy"],"prefix":"10.3389","volume":"15","author":[{"given":"Tongsong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengcheng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linli","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aijie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.12.655","article-title":"Distribution, risk factors, and temporal trends for lung cancer incidence and mortality: A global analysis","volume":"161","author":"Huang","year":"2022","journal-title":"Chest"},{"key":"B3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jtho.2022.10.002","article-title":"SCLC: epidemiology, risk factors, genetic susceptibility, molecular pathology, screening, and early detection","volume":"18","author":"Wang","year":"2023","journal-title":"J Thorac Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0058","article-title":"Small cell lung cancer, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"19","author":"Ganti","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01639","article-title":"Radiation and systemic therapy for limited-stage small-cell lung cancer","volume":"40","author":"Bogart","year":"2022","journal-title":"J Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71207-0","article-title":"Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"065010","DOI":"10.1088\/2057-1976\/ac240c","article-title":"Virtual bronchoscopy-guided lung SAbR: dosimetric implications of using AAA versus Acuros XB to calculate dose in airways","volume":"7","author":"Kinkopf","year":"2021","journal-title":"BioMed Phys Eng Express"},{"key":"B8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrclinonc.2009.188","article-title":"Stereotactic body radiation therapy: a novel treatment modality","volume":"7","author":"Lo","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.radonc.2020.07.012","article-title":"ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer","volume":"152","author":"Le Pechoux","year":"2020","journal-title":"Radiother Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S2213-2600(24)00189-9","article-title":"High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial","volume":"12","author":"Yu","year":"2024","journal-title":"Lancet Respir Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30742-7","article-title":"High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial","volume":"22","author":"Gr\u00f8nberg","year":"2021","journal-title":"Lancet Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199901283400403","article-title":"Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide","volume":"340","author":"Turrisi","year":"1999","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2015.1092584","article-title":"Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer","volume":"55","author":"Gr\u00f8nberg","year":"2016","journal-title":"Acta Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2021.05.003","article-title":"Moderately hypofractionated once-daily compared with twice-daily thoracic radiation therapy concurrently with etoposide and cisplatin in limited-stage small cell lung cancer: A multicenter, phase II, randomized trial","volume":"111","author":"Qiu","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01146","article-title":"Current management and progress in radiotherapy for small cell lung cancer","volume":"10","author":"Tjong","year":"2020","journal-title":"Front Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2004.02.066","article-title":"Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer","volume":"61","author":"Miller","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.3.705","article-title":"73.6 Gy and beyond: hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer","volume":"19","author":"Maguire","year":"2001","journal-title":"J Clin Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/SAP.0000000000003723","article-title":"A review of radiation-induced vascular injury and clinical impact","volume":"92","author":"Kameni","year":"2024","journal-title":"Ann Plast Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.06.2055","article-title":"Retrospective cohort study of bronchial doses and radiation-induced atelectasis after stereotactic body radiation therapy of lung tumors located close to the bronchial tree","volume":"87","author":"Karlsson","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2404873","article-title":"Durvalumab after chemoradiotherapy in limited-stage small-cell lung cancer","volume":"391","author":"Cheng","year":"2024","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01359","article-title":"High-dose once-daily thoracic radiotherapy in limited-stage small-cell lung cancer: CALGB 30610 (Alliance)\/RTOG 0538","volume":"41","author":"Bogart","year":"2023","journal-title":"J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.40673","article-title":"Prognostic factors in limited-stage small cell lung cancer: A secondary analysis of CALGB 30610-RTOG 0538","volume":"7","author":"Farris","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.lungcan.2021.04.016","article-title":"Short Communication: Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance)\/RTOG 0538","volume":"156","author":"Bogart","year":"2021","journal-title":"Lung Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2005.11.007","article-title":"Radiation-induced narrowing of the tracheobronchial tree: an in-depth analysis","volume":"52","author":"Kelsey","year":"2006","journal-title":"Lung Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181915028","article-title":"Late complications of high-dose (>\/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancer","volume":"4","author":"Lee","year":"2009","journal-title":"J\u00a0Thorac Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000453","article-title":"Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned","volume":"10","author":"Chang","year":"2015","journal-title":"J Thorac Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.05.026","article-title":"Central airway toxicity after high dose radiation: A combined analysis of prospective clinical trials for non-small cell lung cancer","volume":"108","author":"Wang","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(96)00353-7","article-title":"High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer: unusual toxicity and promising early results","volume":"36","author":"King","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2017.02.055","article-title":"Surgical treatment of complications after high-dose chemoradiotherapy for lung cancer","volume":"104","author":"Dickhoff","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijrobp.2021.09.027","article-title":"A story of hypofractionation and the table on the wall","volume":"112","author":"Timmerman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1566693\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T05:15:57Z","timestamp":1747631757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1566693\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":30,"alternative-id":["10.3389\/fonc.2025.1566693"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1566693","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"article-number":"1566693"}}